When preparing for a meeting with the U.S. Food and Drug Administration (FDA), sponsors often focus on regulatory, clinical, and medical leadership. But one role is increasingly central — and often overlooked: the statistician.
Whether you’re preparing for a Type B meeting to discuss a pivotal trial or seeking alignment on a protocol or statistical analysis plan, statistical expertise plays a critical role in how the FDA evaluates your program.
What Value Does a Strategic Statistician Provide?
Strategic statisticians have a special and similar mission to FDA: they seek to objectively measure product efficacy and safety and interpret the scientific evidence to quantify risk, thereby facilitating regulatory decision-making.
What Is a Statistician’s Role in FDA Meetings?
FDA reviewers don’t just look at results from clinical trials. They examine the validity of your trial designs, statistical approach, the assumptions underpinning your analyses, and the robustness of your conclusions. Here are 3 ways that a strategic statistician plays a crucial role:
1. They can defend the Study Design and Analysis Methods
Good statisticians can clearly and succinctly articulate and defend:
- The choice of primary and secondary endpoints
- Sample size justifications
- Handling of missing data
- Multiplicity adjustments
- Modeling approaches (e.g., MMRM, Cox models)
FDA will scrutinize these choices, and a statistician fluent in regulatory expectations ensures your design and methods, especially innovative ones, hold up under pressure. The reviewers will want to clearly understand the methods used by the statistician to minimize bias and the extent to which those methods were successful after the trial is complete.
They will also want to understand the methodological and statistical assumptions, the extent to which any of those assumptions were violated (and the possible impact of such violations). They will want to understand the results of any supplemental analyses conducted to better interpret a study’s findings and patterns of results across studies to understand the use case and risk benefit of that product. In sum, it’s not just about number crunching and reporting p-values. It’s the interpretation of the trial results in a broader, more rigorous context that helps the FDA understand them.
2. They Can Communicate Complex Concepts Clearly
The best statisticians translate complexity into clarity. In a regulatory meeting, strategic statisticians understand how to explain in a simple and easy way why, for example, a noninferiority margin is appropriate or how intercurrent events were handled.
They use different techniques (e.g., graphs and tables) to help all participants — not just the FDA statistician — understand complex statistical methods, patterns of trial results, and data interpretations, all with the broader picture in mind.
3. They Can Respond to FDA Questions in Real Time
Meetings with FDA often include on-the-spot questions, such as:
- “What would the power be if you used a different endpoint?”
- “How sensitive is your primary result to assumptions about missing data?”
- “Please explain why you are using MMRM instead of mean imputation for missing data.”
A skilled, strategic statistician can answer these questions credibly and competently, strengthening your position and demonstrating objectivity and scientific rigor. With the statistician present at your meeting, you can benefit from immediate responses to FDA questions and foster more productive discussions. Rather than defaulting to a less desirable post-meeting follow-up, you can walk away from the interaction with a clearer picture of what work still remains and what the final product submission requires.
How Do I Know If I Need a Strategic Statistician on My Team?
Most companies don’t have strategic statisticians with deep methodological, statistical, and regulatory expertise available at their fingertips. Hiring an experienced statistical consultant, particularly one with FDA meeting experience, offers several unique advantages:
✅ Comprehensive Support to Expedite Development and Save Money
A strategic consultant with deep methodological expertise can help you choose the best trial designs (e.g., traditional, adaptive, basket/umbrella, seamless) and enrichment methods to improve efficiency, enhance the quality and quantity of data, and reduce costs.
They can also identify efficacy and safety endpoints that help to target therapies more precisely, with fewer patients needed to declare success. Finally, they can use innovative statistical methods to increase power, predict outcomes more accurately, or leverage prior knowledge to better understand patterns and relationships in data.
✅ Regulatory Expertise and Experience to Streamline Discussions
A strategic consultant brings insight from past FDA interactions across multiple therapeutic areas. They understand how reviewers think and can anticipate objections before you step into the room. They also help FDA’s non-statistical reviewers understand the methods and statistical complexities of a trial, thereby avoiding additional content-related questions.
✅ Objective Review of Your Plans to Determine Regulatory Alignment
Unlike internal team members, consultants can offer independent, unbiased feedback on your trial design and statistical analysis plan. They’ll spot issues your internal team might overlook and will be able to interpret data in a more objective fashion.
✅ Preparation for the FDA Meeting Itself
A good statistical consultant will help you:
- Draft and refine FDA questions and background package sections related to trial methodologies and results
- Prepare statistical considerations as part of mock FDA Q&A sessions
- Ensure your statistical methods, results, and interpretations are regulatory-grade
✅ Credibility and Confidence to Assure FDA Reviewers and Strengthen Internal Conversations
Having a known, experienced statistical consultant signals to FDA that your protocol, statistical analysis plan, and final study report have been vetted by an expert. It also boosts your internal team’s confidence when responding to technical questions. When every interaction can strengthen or undermine the submission’s overall success, this human component is a key consideration.
When Should I Engage a Strategic Statistical Consultant in My Development Timeline?
Ideally, you should bring a strategic statistician into the process early, well before an FDA meeting:
- During protocol development
- Before drafting the statistical analysis plan (SAP)
- Before writing the meeting request and background package
Even if you already have internal statisticians, a consultant can serve as a second set of eyes and a valuable bridge to align trial design and interpretation with the FDA’s statistical reviewers in mind.
The strategic statistician’s role in FDA meetings is no longer optional. It’s critical.
Regulatory success increasingly depends not just on your clinical data, but on the statistical story behind it. Hiring a strategic statistical consultant ensures you’re telling the right story, in the right way, to the right audience.
If you’re preparing for an FDA interaction or want a second set of expert eyes on your development strategy, we’re here to help.
gET sOCIAL